Skip to Content

Standard BioTools Inc LAB

Morningstar Rating
$2.71 +0.02 (0.74%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LAB is trading at a 30% discount.
Price
$2.69
Fair Value
$1.49
Uncertainty
Very High
1-Star Price
$5.81
5-Star Price
$3.42
Economic Moat
Vywk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LAB is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$2.69
Day Range
$2.682.78
52-Week Range
$1.463.16
Bid/Ask
$2.66 / $2.72
Market Cap
$786.22 Mil
Volume/Avg
1.9 Mil / 2.0 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.02
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.52%

Company Profile

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Value
Total Number of Employees
539

Comparables

Valuation

Metric
LAB
PACB
TIHE
Price/Earnings (Normalized)
Price/Book Value
1.43
Price/Sales
2.024.74
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
LAB
PACB
TIHE
Quick Ratio
1.237.03
Current Ratio
1.457.81
Interest Coverage
−15.25−21.18
Quick Ratio
LAB
PACB
TIHE

Profitability

Metric
LAB
PACB
TIHE
Return on Assets (Normalized)
−15.05%−15.38%
Return on Equity (Normalized)
−41.87%
Return on Invested Capital (Normalized)
−16.60%
Return on Assets
LAB
PACB
TIHE
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncGjxxnkcgsVqhsv$221.6 Bil
DHR
Danaher CorpJhncrgqfxCjvkll$184.9 Bil
IQV
IQVIA Holdings IncBycdkvzJdsfl$46.0 Bil
IDXX
IDEXX Laboratories IncLctlwvlgmsYqsqglc$44.8 Bil
A
Agilent Technologies IncSrkrchwkPfqvp$42.6 Bil
MTD
Mettler-Toledo International IncMzjzvtcljbBdcpf$28.5 Bil
ICLR
Icon PLCGfrvqcfWgflqv$27.7 Bil
ILMN
Illumina IncXdddrpspxMgkvnkp$21.8 Bil
WAT
Waters CorpHpdsbrxpDvblz$20.4 Bil
LH
Laboratory Corp of America HoldingsKzhswzkbxjKmzgmh$18.4 Bil

Sponsor Center